Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 22
406
Views
0
CrossRef citations to date
0
Altmetric
Short Communications

Understanding the molecular mechanism of the effect of ginkgo folium on the treatment of IgA nephropathy using network pharmacology and molecular docking

ORCID Icon, , &
Pages 5836-5841 | Received 16 Aug 2021, Accepted 02 Dec 2021, Published online: 19 Dec 2021
 

Abstract

This work focused on identifying the molecular target of Ginkgo Folium (GF) for treating IgA nephropathy and underlying mechanism through network pharmacology (NP). The active components and targets of GF and targets associated with IgAN were obtained by TCMSP database, DrugBank etc. The key targets of GF against IgAN were searched by network topology. The drug-disease intersection targets were performed GO functional annotation as well as KEGG pathway analysis, and molecular docking (MD) was conducted to verify the degree of combination of the target and ligand. Three core compounds and seven key targets were found by topological analysis. GO and KEGG results suggested that GF effect on IgAN was strongly associated with OS cellular response and AGE-RAGE pathways. Molecular docking of the three core components with AKT1 indicated that they had good binding activity. Ginkgo biloba had multicomponent, multitarget, and multi-pathway effects on IgAN.

Graphical Abstract

Disclosure statement

No potential competing interest was reported by the authors.

Additional information

Funding

This research was supported by Special Science Research Fundation of Sichuan Administration of Traditional Chinese Medicine of China (NO.2021MS373).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.